Colgate-Palmolive records higher Q3 sales as revenue reaches $5.37 billion
Pontos principais
- Colgate-Palmolive (NYSE:CL) reported third-quarter 2026 net sales of $5.37 billion, up 4.6% year over year.
- Adjusted EPS reached $0.97, beating analyst expectations of approximately $0.92–$0.93, while GAAP net income increased to $751 million.
- The company narrowed its full-year sales growth guidance to 4%–5% and raised its outlook for base business EPS and gross profit margins.
Colgate-Palmolive (NYSE:CL) reported third-quarter 2026 net sales of $5.37 billion, up 4.6% year over year, while adjusted earnings per share reached $0.97, exceeding analyst expectations.
Revenue surpassed the approximately $5.34 billion analyst estimate, while GAAP diluted EPS increased 3% to $0.94 from $0.91 in the third quarter of 2025.
The company reported that global organic sales increased 3.6%, with volume growth improving for the fourth consecutive quarter.
GAAP net income attributable to Colgate-Palmolive increased to $751 million from $735 million a year earlier, while GAAP gross profit margin expanded 80 basis points to 60.2%.
The company narrowed its full-year 2026 net sales growth outlook to 4%–5% and raised its expectations for full-year base business earnings per share and gross profit margins.
Meanwhile, Colgate-Palmolive's adjusted EPS of $0.97 exceeded the analyst consensus of approximately $0.92–$0.93.
Colgate-Palmolive operates across oral care, personal care, home care and pet nutrition markets, with brands including Colgate, Palmolive, Ajax, Hill's Science Diet and other consumer products.
